Brief: Xbrane Says FDA Approved Lucamzi
27/10/2026 14:42
BRIEF-Xbrane Says FDA Approved Lucamzi Oct 27 (Reuters) - Xbrane Biopharma AB XBRANE.ST:
FDA APPROVES LUCAMZI (RANIBIZUMAB-BLRZ) BIOSIMILAR TO LUCENTIS IN THE U.S.
TO FINALIZE PREPARATIONS FOR LUCAMZI U.S. LAUNCH DURING 2027
Source text: ID:nMFN8P0ZYd
Further company coverage: XBRANE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))